首页> 外文期刊>Crystal growth & design >Polymorphism of Progesterone: A New Approach for the Formation of Form II and the Relative Stabilities of Form I and Form II
【24h】

Polymorphism of Progesterone: A New Approach for the Formation of Form II and the Relative Stabilities of Form I and Form II

机译:孕酮的多态性:形成形式II和形式I和形式II的相对稳定性的新方法

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, a novel technique has been developed for producing progesterone form II crystals by using shear-assisted sonocrystallization (SAS) method. Progesterone, a steroid hormone, has been recognized for more than 70 years as having two polymorphs, a stable form (form I) and a metastable form (form II). Previous attempts have failed to produce a single crystal of form II of progesterone without the presence of a cocrystal additive or template. The technique proposed in the current study is the first to report the growth of single crystals of progesterone form II. The produced crystals were characterized using X-ray diffraction, differential scanning calorimeter, and Fourier transform infrared spectroscopy. Single crystal X-ray diffraction was performed for comparing the hydrogen bond geometry of forms I and II. Solubility and dissolution rates were estimated, providing insight on the thermodynamics of both forms. Stability studies of both forms were conducted for 60 days, which confirmed the higher stability of progesterone form I. Comparing the crystal structure of form I and form II provides evidence for their relative stabilities. The SAS technique can be proposed as a novel strategy for polymorphic transformation of progesterone, which can increase the dissolution rate, enhance oral bioavailability, and decrease dose-related side effects.
机译:在本研究中,已开发出一种新技术,通过使用剪切辅助声结晶(SAS)方法生产孕酮II型晶体。孕酮是一种类固醇激素,已有70多年的历史了,它具有两种多晶型物,一种是稳定形式(形式I),另一种是亚稳态形式(形式II)。在没有共晶添加剂或模板的情况下,先前的尝试未能产生孕酮的II型单晶。当前研究中提出的技术是第一个报告孕酮II型单晶生长的技术。使用X射线衍射,差示扫描量热仪和傅立叶变换红外光谱对生成的晶体进行表征。进行单晶X射线衍射以比较形式I和II的氢键几何形状。估计了溶解度和溶解速度,从而提供了两种形式的热力学的见解。两种形式的稳定性研究进行了60天,这证实了I型孕酮的较高稳定性。比较I型和II型孕酮的晶体结构为其相对稳定性提供了证据。 SAS技术可以作为孕酮多态转化的一种新策略而提出,它可以提高溶出率,提高口服生物利用度并减少剂量相关的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号